The CADTH Scientific Advice Program is a voluntary, non-binding, and confidential fee-for-service consultation. Through this Program, pharmaceutical companies are provided with advice on their early drug development plans from a Canadian health technology assessment perspective.
CADTH is pleased to announce a new collaboration with England’s NICE (National Institute for Health and Care Excellence) to offer parallel scientific advice to pharmaceutical companies. Applications are now being accepted. To learn more about this opportunity, please contact CADTH Scientific Advice at firstname.lastname@example.org.
Published : February 6, 2019